Alliance Pharma plc (APH.L)

111.40 +3.20 (+2.96%) At close: 04:35PM BST

Alliance Pharma plc

Avonbridge House
Bath Road
Chippenham SN15 2BB
United Kingdom
44 12 4946 6966
https://www.alliancepharmaceuticals.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 256

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Peter Jonathan Butterfield	CEO & Exec. Director	978.91k	N/A	1976
Mr. Andrew Timothy Franklin	CFO & Exec. Director	417.2k	N/A	1966
Mr. Stephen Kidner	Chief Scientific Affairs & Operations Officer	N/A	N/A	N/A
Mr. Alex Duggan	Chief Commercial & Corp. Devel. Officer	N/A	N/A	N/A
Ms. Janice Timberlake	Chief People & Infrastructure Officer	N/A	N/A	N/A
Mr. Steve Lobb	Head of Hydromol	N/A	N/A	N/A
Mr. David Hope	Head of Secondary Care	N/A	N/A	N/A
Mr. Rajiv Ghidiyal	Head of APAC, EMEA & Americas	N/A	N/A	N/A
Mr. Karim Husny	Head of International	N/A	N/A	N/A
Chris Delafield	Global Marketing Head of Kelo-Cote	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Corporate Governance

Alliance Pharma plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.